Mucinex Childrens Freefrom Multi-Symptom Cold, Flu and Sore Throat

Description

Mucinex® Children's is a multi-symptom formulation designed for the relief of cold, flu, and sore throat symptoms. Each 4 fluid ounce (118 mL) dosage contains acetaminophen as a pain reliever and fever reducer, dextromethorphan HBr as a cough suppressant, guaifenesin as an expectorant, and phenylephrine HCl as a nasal decongestant. The product is free from artificial flavors, colors, and dyes, as well as alcohol and sugar. It features natural elderberry and cherry flavors and is intended for use in children aged 6 years and older.

Uses and Indications

This drug is indicated for the temporary relief of common cold and flu symptoms, including cough, nasal congestion, minor aches and pains, sore throat, headache, stuffy nose, and sinus congestion and pressure. Additionally, it temporarily reduces fever and assists in loosening phlegm (mucus) and thinning bronchial secretions, thereby facilitating the expulsion of mucus and enhancing the productivity of coughs.

There are no teratogenic or nonteratogenic effects associated with this drug.

Dosage and Administration

This product is intended for use in children aged 6 years and older. The dosing instructions are as follows:

For children aged 6 to under 12 years, the recommended dose is 10 mL, administered using the dosing cup provided, every 4 hours as needed while symptoms persist. It is important not to exceed 5 doses within a 24-hour period.

For children under 6 years of age, the use of this product is not recommended.

Healthcare professionals should ensure that the dosing cup provided is used exclusively for this product and not with any other medications. Additionally, it is crucial to adhere strictly to the dosing guidelines to avoid the risk of overdose.

Contraindications

The use of this product is contraindicated in the following situations:

• Co-administration with any other drug containing acetaminophen, whether prescription or nonprescription, due to the risk of acetaminophen overdose. Healthcare professionals should verify the presence of acetaminophen in other medications if there is uncertainty.

• In pediatric patients who are currently taking a prescription monoamine oxidase inhibitor (MAOI) or within 2 weeks of discontinuing such treatment. MAOIs are commonly prescribed for depression, psychiatric or emotional conditions, and Parkinson's disease. Consultation with a healthcare provider is advised if there is any doubt regarding the presence of an MAOI in the child's medication regimen.

• Exceeding the recommended dosage is contraindicated, as it may lead to overdose and associated complications.

Warnings and Precautions

This product contains acetaminophen, which poses a risk of severe liver damage if the child exceeds the maximum daily dosage of 5 doses within a 24-hour period or if it is taken concurrently with other medications containing acetaminophen. Healthcare professionals should be vigilant regarding the potential for severe skin reactions associated with acetaminophen use. Symptoms may include skin reddening, blisters, and rash. Should any skin reaction occur, it is imperative to discontinue use immediately and seek medical assistance.

In cases of severe sore throat that persists for more than 2 days or is accompanied by fever, headache, rash, nausea, or vomiting, prompt consultation with a physician is advised.

It is crucial to avoid the concurrent use of this product with any other medications containing acetaminophen, whether prescription or nonprescription. If there is uncertainty regarding the presence of acetaminophen in other medications, healthcare professionals should recommend consulting a doctor or pharmacist. Additionally, this product should not be administered to children who are currently taking a prescription monoamine oxidase inhibitor (MAOI) or within 2 weeks of discontinuing such medication. If there is any doubt about the presence of an MAOI in the child's prescription, a healthcare professional should be consulted prior to administration.

Before using this product, healthcare providers should inquire about the child's medical history, particularly regarding liver disease, heart disease, high blood pressure, thyroid disease, diabetes, persistent or chronic cough (such as that associated with asthma), or cough accompanied by excessive phlegm. Furthermore, it is advisable to consult a doctor or pharmacist if the child is taking the anticoagulant warfarin.

When administering this product, it is essential to adhere strictly to the recommended dosage and not exceed the directed amount.

In the event of an overdose, immediate medical attention should be sought, or contact with a Poison Control Center should be made without delay, as rapid intervention is critical even in the absence of noticeable signs or symptoms.

Healthcare professionals should instruct caregivers to discontinue use and consult a physician if the child experiences nervousness, dizziness, or sleeplessness; if pain, nasal congestion, or cough worsens or persists beyond 5 days; if fever worsens or lasts more than 3 days; if redness or swelling occurs; if new symptoms arise; or if a cough recurs or is accompanied by fever, rash, or headache lasting longer than expected, as these may indicate a serious underlying condition.

Side Effects

Severe adverse reactions associated with this product include the potential for severe liver damage, particularly in patients who exceed the maximum daily dosage of five doses within a 24-hour period or who concurrently use other medications containing acetaminophen. Patients should be advised that acetaminophen may also lead to severe skin reactions, which can manifest as skin reddening, blisters, or rash. In the event of any skin reaction, it is imperative to discontinue use and seek immediate medical assistance.

Patients experiencing a severe sore throat that persists for more than two days, or is accompanied by fever, headache, rash, nausea, or vomiting, should consult a healthcare professional promptly.

This product should not be used in conjunction with any other medications containing acetaminophen, whether prescription or nonprescription. Additionally, it is contraindicated in children who are currently taking a prescription monoamine oxidase inhibitor (MAOI) or have taken one within the past two weeks. If there is uncertainty regarding the presence of an MAOI in a child's medication, consultation with a healthcare provider is recommended.

Before administering this product, it is advisable to consult a healthcare professional if the child has a history of liver disease, heart disease, high blood pressure, thyroid disease, diabetes, persistent or chronic cough (such as that associated with asthma), or cough accompanied by excessive phlegm.

Patients taking the anticoagulant warfarin should also seek guidance from a healthcare provider prior to use.

Discontinuation of the product and consultation with a healthcare professional is warranted if the child experiences nervousness, dizziness, or sleeplessness; if pain, nasal congestion, or cough worsens or persists beyond five days; if fever worsens or lasts more than three days; if redness or swelling occurs; if new symptoms develop; or if cough recurs with fever, rash, or headache lasting longer than expected, as these may indicate a serious condition.

An overdose of this product may result in liver damage. In the event of an overdose, it is crucial to seek medical help or contact a Poison Control Center immediately, as prompt medical attention is essential even if no signs or symptoms are initially apparent.

Drug Interactions

Co-administration of this medication with any other drug containing acetaminophen, whether prescription or nonprescription, is contraindicated due to the risk of acetaminophen overdose, which can lead to severe liver damage.

In pediatric patients, the use of this medication is contraindicated in those who are concurrently taking a prescription monoamine oxidase inhibitor (MAOI) or have taken an MAOI within the past two weeks. MAOIs are typically prescribed for conditions such as depression, certain psychiatric disorders, or Parkinson's disease, and their interaction with this medication may lead to serious adverse effects.

Additionally, it is advisable to consult a healthcare professional, such as a doctor or pharmacist, prior to administering this medication to a child who is taking the anticoagulant warfarin. Monitoring may be necessary to ensure safe use and to avoid potential interactions that could affect coagulation parameters.

Packaging & NDC

Below are the non-prescription pack sizes of Mucinex Childrens Freefrom Multi-Symptom Cold, Flu and Sore Throat (acetaminophen, dextromethorphan hydrobromide, guaifenesin, and phenylephrine hydrochloride). Columns show Packaging, Formulation Type, and Active Ingredient Strength.

Pediatric Use

Pediatric patients aged 6 to under 12 years may receive a dosage of 10 mL using the dosing cup provided every 4 hours as needed, with a maximum of 5 doses in a 24-hour period. The use of this medication is not recommended for children under 6 years of age.

Healthcare professionals should advise caregivers to consult a doctor prior to administration if the child has any of the following conditions: liver disease, heart disease, high blood pressure, thyroid disease, diabetes, or a persistent or chronic cough, such as that associated with asthma, or if the cough is accompanied by excessive phlegm (mucus). Additionally, it is important to seek guidance from a doctor or pharmacist if the child is concurrently taking the anticoagulant medication warfarin.

Geriatric Use

There is no specific information regarding the use of Mucinex Children's FreeFrom Multi-Symptom Cold, Flu, and Sore Throat in geriatric patients. Therefore, healthcare providers should exercise caution when considering this medication for elderly patients.

Due to the lack of clinical data in this population, it is advisable to monitor geriatric patients closely for any adverse effects or unusual responses to treatment. Additionally, healthcare providers may need to consider potential age-related physiological changes that could affect drug metabolism and clearance when prescribing this medication.

As always, individualized patient assessment is essential to ensure safety and efficacy in the geriatric population.

Pregnancy

The safety of this product during pregnancy has not been established. Pregnant patients or those planning to become pregnant should consult a healthcare provider before use, as there may be potential risks to the fetus; however, specific studies or data regarding these risks are not provided in the prescribing information. No specific dosage modifications for pregnant individuals are mentioned, underscoring the importance of seeking medical advice prior to use. Healthcare professionals are advised to carefully consider the potential risks and benefits when discussing this product with women of childbearing potential.

Lactation

There are no specific warnings or recommendations regarding nursing mothers or lactation in the provided text. Therefore, healthcare professionals may consider the use of this medication in lactating mothers without specific concerns related to breastfeeding. However, it is always advisable to monitor breastfed infants for any potential adverse effects when the mother is taking any medication.

Renal Impairment

Patients with renal impairment have not been specifically addressed in the drug insert regarding dosage adjustments, special monitoring, or safety considerations. Therefore, healthcare professionals should exercise caution when prescribing this medication to individuals with reduced kidney function, as the absence of detailed guidance necessitates careful clinical judgment. Regular monitoring of renal function may be advisable in these patients to ensure safety and efficacy.

Hepatic Impairment

Patients with hepatic impairment should exercise caution when using this product, which contains acetaminophen. It is important to note that severe liver damage may occur if the maximum daily amount of more than 5 doses is exceeded within a 24-hour period. Additionally, the risk of liver damage increases if this product is taken concurrently with other medications containing acetaminophen.

Before administering this product, it is advisable to consult a healthcare professional if the patient has a history of liver disease. Patients with compromised liver function should be closely monitored for any signs of liver damage, particularly in the context of potential overdose. Taking more than the recommended dose can lead to serious liver injury. In the event of an overdose, immediate medical attention is essential, and contacting a Poison Control Center is recommended, even if no symptoms are apparent. Quick intervention is critical to mitigate the risk of severe liver damage.

Overdosage

In the event of an overdose, defined as the ingestion of more than the recommended dose, there is a significant risk of liver damage. Healthcare professionals should be aware that the severity of the effects may not be immediately apparent, as symptoms can be delayed or absent initially.

It is imperative that individuals who suspect an overdose seek medical assistance promptly. Contacting a Poison Control Center or obtaining medical help without delay is crucial for effective management. Quick medical attention is essential, even in the absence of noticeable signs or symptoms, to mitigate potential complications and ensure appropriate treatment is administered.

Healthcare providers should remain vigilant and prepared to assess and manage any cases of overdose, emphasizing the importance of early intervention in safeguarding patient health.

Nonclinical Toxicology

No teratogenic or non-teratogenic effects have been reported in the available nonclinical studies. Additionally, there is no information regarding animal pharmacology and toxicology. The absence of data limits the understanding of potential risks associated with the compound in nonclinical settings.

Postmarketing Experience

Reports of side effects have been received through voluntary submissions and surveillance programs. Healthcare professionals and patients are encouraged to report any adverse events to the designated contact number provided for this purpose.

Patient Counseling

Healthcare providers should advise patients to keep this medication out of reach of children to prevent accidental ingestion. It is important to inform patients not to use this product in conjunction with any other medication containing acetaminophen, whether prescription or nonprescription. If patients are uncertain whether a drug contains acetaminophen, they should be encouraged to consult a doctor or pharmacist.

Patients should be cautioned against using this product in children who are currently taking a prescription monoamine oxidase inhibitor (MAOI) or within two weeks of stopping such medication. If there is any uncertainty regarding the presence of an MAOI in a child's prescription, patients should seek guidance from a healthcare professional.

Patients should be instructed to discontinue use and consult a doctor if they experience nervousness, dizziness, or sleeplessness. Additionally, they should be advised to stop use and seek medical advice if pain, nasal congestion, or cough worsens or persists for more than five days, or if fever worsens or lasts more than three days. They should also be informed to stop use and consult a doctor if any redness or swelling occurs, if new symptoms arise, or if a cough returns or occurs with fever, rash, or a headache that lasts, as these may indicate a serious condition.

When using this product, patients must be reminded not to exceed the recommended dosage, and they should be made aware of the overdose warning. It is essential for patients to consult a doctor before use if the child has any of the following conditions: liver disease, heart disease, high blood pressure, thyroid disease, diabetes, or a persistent or chronic cough, such as that associated with asthma. Furthermore, patients should be advised to seek medical advice if the child has a cough accompanied by excessive phlegm (mucus) or if the child is taking the blood-thinning medication warfarin.

Storage and Handling

The product is supplied in various package configurations, with specific NDC numbers available for identification. It is essential to store the product at a temperature range of 20-25°C (68-77°F). Refrigeration is not permitted, as it may compromise the integrity of the product. Proper handling and storage conditions must be adhered to in order to maintain the product's efficacy and safety.

Additional Clinical Information

The medication is administered orally, with specific dosing guidelines based on age. For children aged 6 to under 12 years, the recommended dose is 10 mL, taken every 4 hours as needed, not to exceed 5 doses within a 24-hour period. The medication is not recommended for children under 6 years of age.

There is no additional information available regarding laboratory tests, abuse potential, patient counseling, or postmarketing experience.

Drug Information (PDF)

This file contains official product information for Mucinex Childrens Freefrom Multi-Symptom Cold, Flu and Sore Throat, including active ingredients, dosage, warnings, and labeling as submitted by the manufacturer for OTC distribution.

View product document (PDF)